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Original articleMuscle insulin sensitivity and glucose metabolism
are controlled by the intrinsic muscle clockKenneth A. Dyar 1,*, Stefano Ciciliot 1, Lauren E. Wright 2, Rasmus S. Biensø 3,
Guidantonio M. Tagliazucchi 4, Vishal R. Patel 5, Mattia Forcato 4, Marcia I.P. Paz 1, Anders Gudiksen 3,
Francesca Solagna 1, Mattia Albiero 1, Irene Moretti 1,6, Kristin L. Eckel-Mahan 7, Pierre Baldi 5,
Paolo Sassone-Corsi 7, Rosario Rizzuto 2,6, Silvio Bicciato 4, Henriette Pilegaard 3,
Bert Blaauw 1,2, Stefano Schiaffino 1,6,*ABSTRACTCircadian rhythms control metabolism and energy homeostasis, but the role of the skeletal muscle clock has never been explored. We generated
conditional and inducible mouse lines with muscle-speciﬁc ablation of the core clock gene Bmal1. Skeletal muscles from these mice showed
impaired insulin-stimulated glucose uptake with reduced protein levels of GLUT4, the insulin-dependent glucose transporter, and TBC1D1, a Rab-
GTPase involved in GLUT4 translocation. Pyruvate dehydrogenase (PDH) activity was also reduced due to altered expression of circadian genes Pdk4
and Pdp1, coding for PDH kinase and phosphatase, respectively. PDH inhibition leads to reduced glucose oxidation and diversion of glycolytic
intermediates to alternative metabolic pathways, as revealed by metabolome analysis. The impaired glucose metabolism induced by muscle-speciﬁc
Bmal1 knockout suggests that a major physiological role of the muscle clock is to prepare for the transition from the rest/fasting phase to the active/
feeding phase, when glucose becomes the predominant fuel for skeletal muscle.
& 2013 The Authors. Published by Elsevier GmbH.
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Open access under CC BY-NC-SA license.1. INTRODUCTION
Circadian rhythms and energy metabolism are inextricably linked. While
many behavioral and physiological processes linked to energy metabo-
lism show daily ﬂuctuations under the control of an endogenous
circadian clock and environmental cues, the circadian clock is itself
inﬂuenced by feeding and activity rhythms, and ultimately metabolic
state [1–3]. The regulation of body metabolism by normal circadian
rhythms has important clinical implications, since chronic circadian
misalignment, as occurs in shift work, is associated with a higher
prevalence of insulin resistance, obesity, metabolic syndrome and
diabetes [4–6].
The circadian timing system is composed of a central pacemaker
located in the suprachiasmatic nucleus (SCN) of the hypothalamus and
autonomous molecular oscillators present in all cells of the body. At the
cellular level, the core of this 24-h rhythm generating oscillator is
composed of molecular feedback loops [7]. In the major loop, the
transcription factors BMAL1 and CLOCK bind as heterodimers to thehttp://dx.doi.org/10.1016/j.molmet.2013.10.005
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negative feedback, PER and CRY proteins translocate to the nucleus and
repress the CLOCK:BMAL1 complex. In a second regulatory loop, the
expression of Bmal1 (Arntl) is controlled by CLOCK:BMAL1-dependent
transcriptional activators of the ROR family, such as RORα, and
repressors of the REV-ERB family, such as REV-ERBα. In addition to
the core clock genes, all tissues contain a large number of oscillating
genes, most of which are tissue-speciﬁc and regulated either directly by
the core oscillator or by extrinsic circadian signals [7].
An important role for circadian clocks in the regulation of glucose
metabolism is supported by genome-wide DNA-binding analyses and by
ablation of clock genes. A time-resolved and genome-wide map of
BMAL1 binding in mouse liver, derived from ChIP-seq analyses, has
shown that carbohydrate metabolism is a major output of the circadian
clock in this tissue [8]. Global inactivation of different clock genes
leads to altered glucose metabolism: Clock mutant mice display
hyperglycemia, obesity and metabolic syndrome [9]; Per1/Per2 double
knockout mice and Cry1/Cr2 double knockout mice exhibit glucoses; imKO, inducible muscle-specific Bmal1 knockout; HK2, hexokinase 2; KHB, Krebs–Henseleit buffer;
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Original articleintolerance [10,11]; Bmal1 null mice are also glucose intolerant, and
show altered gluconeogenesis [10,12]. In addition, the normal circadian
rhythm of increased insulin sensitivity during the active/feeding phase is
completely abolished in global Bmal1 null mice [13].
Interpretation of whole body knockout studies is complicated by the fact
that all tissues are affected, including both the central pacemaker and
peripheral clocks. The hierarchical role of the central pacemaker was
demonstrated by the ﬁnding that circadian rhythms of blood glucose,
insulin and glucagon, as well as glucose tolerance, are all abolished by
SCN lesion [14]. An equally important role for peripheral oscillators has
been demonstrated by tissue-speciﬁc knockout of clock genes, with
distinct effects depending on the tissue. Selective knockout of Bmal1 in
the liver causes hypoglycemia [10], while ablation of the same gene in
the endocrine pancreas leads to fasting hyperglycemia and severe
glucose intolerance [15]. Local insulin sensitivity was found to be normal
in mice lacking Bmal1 selectively in the liver or adipose tissue [10,16].
Although skeletal muscle is a primary site of insulin-dependent glucose
disposal, the speciﬁc role the muscle clock plays in regulating glucose
uptake and metabolism is not known. A daily rhythm in plasma glucose
concentration has been described in both animals and humans, with a
peak just before the start of the main activity period, reﬂecting
ﬂuctuations in glucose export, glucose uptake and insulin sensitivity
[14]. However, it is not clear whether these circadian rhythms are
controlled by peripheral clocks in muscle and adipose tissue, or by
humoral or neural signals emanating from the SCN. A circadian rhythm
of glucose uptake was also demonstrated in muscle cell cultures, but
these daily ﬂuctuations were observed both in basal and insulin-
stimulated conditions [17]. To understand the physiological role the
intrinsic muscle clock plays in glucose metabolism, we have generated
two skeletal muscle-speciﬁc Bmal1 knockout models. We report here
that muscle-speciﬁc Bmal1 ablation causes impaired insulin-dependent
glucose uptake and reduced glucose oxidation in skeletal muscle, and
we identify potential mechanisms involved in mediating these effects.2. MATERIALS AND METHODS
2.1. Animals
Muscle-speciﬁc inactivation of Bmal1 (mKO) was obtained from the
cross between a C57BL/6 mouse line with ﬂoxed Bmal1 [18] and a
C57BL/6 mouse line carrying a Cre recombinase transgene under
control of the Mlc1f promoter (Mlc1f–Cre) [19]. In the resulting mKO
mice, the region coding for the BMAL1 basic helix–loop–helix DNA
binding domain is excised. Cre-negative littermates were used as
controls.
A second knockout model with inducible muscle-speciﬁc inactivation of
Bmal1 (imKO) was obtained by crossing the Bmal1 ﬂoxed line with mice
carrying an α-skeletal actin driven Cre recombinase fused to a mutated
estrogen receptor [20], which can be activated by treatment with
tamoxifen (i.p. 1 mg/day for 5 days). Cre negative littermates, also
receiving tamoxifen treatment, were used as controls. All strains had
been backcrossed a minimum of 6 times with C57BL/6 mice.
Experimental protocols were reviewed and approved by the local Animal
Care Committee, University of Padova. Animals were housed in a
temperature-controlled room (22 1C) under a 12 h light–dark regimen,
with lights on at ZT0 (6 am), lights off at ZT12 (6 pm), with standard
chow diet (Mucedola, Settimo Milanese, Italy) and water provided ad
libitum. All tissues were collected immediately after cervical dislocation
at ZT0, 4, 8, 12, 16, and 20, snap frozen in liquid nitrogen and stored at
80 1C until subsequent use. To monitor locomotor activity levels, a30 MOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The Autelemetric sensor (PhysioTel, TA10TA-F20, Data Sciences, Inc.) was
implanted i.p. under general anesthesia. Mice were allowed to recover
for at least 2 weeks, and locomotor activity was recorded continuously
for 12 days.
2.2. Immunoﬂuorescence
Cryosections of fast and slow muscles were stained with monoclonal
anti-myosin heavy chain (MyHC) antibodies produced in our lab [21], and
now distributed by the Developmental Studies Hybridoma Bank (DSHB,
University of Iowa): BA-D5 (IgG2b, supernatant, 1:100 dilution) speciﬁc
for MyHC-I, SC-71 (IgG1, supernatant, 1:100 dilution) speciﬁc for MyHC-
2A and BF-F3 (IgM, puriﬁed antibody, 1:100 dilution) speciﬁc for MyHC-
2B. Type 2X ﬁbers are not recognized by these antibodies, and so
appear black. Three different secondary antibodies (Jackson ImmunoR-
esearch) were used to selectively bind to each primary antibody: goat
anti-mouse IgG1, conjugated with DyLight488 ﬂuorophore (to bind to
SC-71); goat anti-mouse IgG2b, conjugated with DyLight405 ﬂuorophore
(to bind to BA-D5); goat anti-mouse IgM, conjugated with DyLight549
ﬂuorophore (to bind to BF-F3). Muscle sections, 8 mm thick, were
incubated with M.O.M. IgG blocking solution (Vector) for 1 h at room
temperature, then brieﬂy washed twice with PBS for 2 min. A solution
with all the primary antibodies in phosphate-buffered saline (PBS)
containing 0.5% of bovine serum albumin (BSA) was then prepared, and
sections were incubated for 1 h at 37 1C. After 3 washes (5 min each)
with PBS, sections were incubated for 30 min at 37 1C with a solution
with the three different secondary antibodies, diluted in PBS containing
0.5% of BSA and 5% of goat serum. After 3 washes with PBS (5 min
each) and a brief rinse in water, sections were mounted with Elvanol. A
control incubation with no primary antibodies was performed, and also
control incubations with each primary antibody and non-speciﬁc
secondary antibodies to exclude any possible cross-reaction. Pictures
were collected with an epiﬂuorescence Leica DM5000 B equipped with
a Leica DFC 300 FX camera. Single-color images were merged to obtain
a whole muscle reconstruction with Adobe Photoshop CS2 (Adobe
Systems Inc.).
2.3. Electron microscopy
Muscles were ﬁxed at resting length in 2.5% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.4. During subsequent washing in phosphate
buffer, small bundles of ﬁbers were dissected from the superﬁcial
regions of the muscles and postﬁxed in 1% OsO4 in phosphate buffer
and treated with uranyl acetate before dehydration and embedding in
Epon. Ultrathin sections were stained with lead citrate.
2.4. Force measurements
In vivo force measurements were performed as described previously
[22]. Brieﬂy, mice were anesthetized and stainless steel electrode wires
were placed on either side of the sciatic nerve. Torque production of the
plantar ﬂexors was measured using a muscle lever system (Model 305c;
Aurora Scientiﬁc, Aurora ON, Canada). The force–frequency curves were
determined by increasing the stimulation frequency in a stepwise
manner, pausing for 30 s between stimuli to avoid effects due to
fatigue. Muscle force was normalized for the weight of the gastro-
cnemius muscle.
2.5. RNA isolation and qPCR
Total RNA was isolated using TRIzol (Invitrogen) followed by cleanup
with the RNeasy Mini Kit (Qiagen). RNA integrity was evaluated with the
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) and
quantiﬁed with a NanoVue spectrophotometer (GE Healthcare Lifethors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-SA license.
Sciences, Baie d'Urfe, QC). Complementary DNA from each sample was
generated from 0.8 μg of RNA reverse-transcribed with Invitrogen
Superscript III reverse transcriptase. Primer sets were designed using
Primer-BLAST (NCBI) and were each validated prior to use by gradient
PCR and gel analysis to test for optimal annealing temperature, reaction
efﬁciency and speciﬁcity. Duplicates of cDNA samples were then
ampliﬁed on the 7900HT Fast Real-Time PCR System (Applied
Biosystems) using the Fast SYBR Green RT-PCR kit (Applied Biosys-
tems). Speciﬁcity of gene ampliﬁcation was conﬁrmed by analyzing the
dissociation curve with SDS 2.4 software (Applied Biosystems). Analysis
was performed using the standard curve method and all data were
normalized relative to 36B4 expression and plotted in arbitrary units as
mean7SEM. Primer sequences are available upon request.2.6. Gene expression proﬁling and analyses
For gene expression proﬁling, 250 ng of RNA from tibialis anterior and
soleus muscles was hybridized to Mouse Gene 1.0 ST Arrays
(Affymetrix) using three biological replicates for each time point.
Expression values were generated from ﬂuorescence signals using the
robust multi-array average procedure (RMA) [23]. Speciﬁcally, intensity
levels have been background adjusted, normalized using quantile
normalization, and log 2 expression values calculated using median
polish summarization and Entrez custom chip deﬁnition ﬁles for mouse
arrays (version 14.1.0) [24]. Differentially expressed genes were
identiﬁed using the microarray Signiﬁcant Proﬁles method coded in
the maSigPro R package [25] with default parameters. Rhythmic genes
that cycle with a 24-h period were identiﬁed using a Benjamini–
Hochberg q-valueo0.2 in the non-parametric algorithm JTK_Cycle
[26]. Over-representation analysis was performed using Gene Set
Enrichment Analysis software (GSEA; http://www.broadinstitute.org/
gsea/index.jsp) [27] and gene sets from the KEGG database. Gene sets
were deﬁned as signiﬁcantly enriched if the False Discovery Rate (FDR)
was o0.25 when using Signal2Noise as metric and 10,000 permuta-
tions of phenotype labels. Expression data are available at Gene
Expression Omnibus under the accession number GSE43071.2.7. Global metabolic proﬁling
Metabolic proﬁling, peak identiﬁcation, and curation were performed by
Metabolon using described methods [28]. Brieﬂy, the non-targeted
metabolic proﬁling platform used by Metabolon combines three
independent platforms: UHPLC/MS/MS optimized for basic species,
UHPLC/MS/MS optimized for acidic species, and GC/MS. We examined
60 muscles (tibialis anterior) from distinct mice, corresponding to control
and muscle-speciﬁc Bmal1 knockout, at 6 time points, 5 muscles per
point. A total of 277 biochemicals were identiﬁed, but only sugar
metabolites will be reported here (see Table S1).2.8. CircadiOmics
All transcriptome and metabolome data are accessible through the
CircadiOmics Website (http://circadiomics.igb.uci.edu), allowing users to
search and view genes of interest and detected metabolites in Ctrl and
Bmal1 mKO skeletal muscles, as well as their interactions and statistics.
Importantly, gene expression and metabolite levels were derived from
contralateral hindlimb muscles from the same animals, allowing for a
more direct correlation of these metabolite–gene interactions. Networks
and subnetworks can be explored and rearranged interactively, provid-
ing a comprehensive systems-level view of the circadian molecular
pathways [29].MOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The Authors. Published by Elsevier GmbH. Open a2.9. Comparative analysis of genomic sequences
For the identiﬁcation of potential binding sites for clock genes, the
genomic sequences for 6 eutherian species (about 400 bp upstream and
400 bp downstream of the relevant binding motif) were analyzed using
the mVISTA tool (http://genome.lbl.gov/vista) and aligned with LAGAN.
The conservation parameters were set as 70% of conservation identity
and 100 bp minimum conservation window.
2.10. Glucose and insulin tolerance tests
Blood glucose was measured after an 8 h fast using a Glucocard Gþ
meter (Arkray Factory, Shiga, Japan). Glucose tolerance tests (GTT) and
insulin tolerance tests (ITT) were performed at ZT12, coinciding with the
hours near awakening and the normal physiological peak of glucose
tolerance and insulin sensitivity [14]. Mice were fasted for 8 h before
analysis during their normal rest/fasting phase. For GTT, mice were
injected i.p. with glucose (2 g/kg body weight). Blood glucose was
measured at 0, 10, 20, 30, 60 and 120 min via the tail vein. For ITT,
mice were injected i.p. with human insulin (0.75 U/kg body weight;
Sigma) and blood glucose was measured at 10, 0, 10, 20, 30, 60,
and 90 min via the tail vein.
2.11. Insulin-stimulated glucose transport in isolated skeletal muscle
All experiments were performed between ZT8 and ZT12 in order to
coincide with the hours immediately before and during awakening, the
normal physiological peak of glucose tolerance and insulin sensitivity
[14]. Mice were sacriﬁced by cervical dislocation and soleus muscles
were rapidly and carefully removed. The method to measure glucose
transport was similar to that described previously [30,31] with some
modiﬁcations [32]. Muscles were pre-incubated for 40 min at 30 1C
under gentle shaking (200 RPM) in 2 mL of a daily prepared, pre-gassed
(1 h, 95% O2þ5% CO2) modiﬁed Krebs–Henseleit buffer (KHB):
118 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM
MgSO4, 15 mM CO2–gassed NaHCO3, 1% fatty acid free bovine serum
albumin (BSA), 5 mM glucose, and 10 mM HEPES. Thereafter, muscles
were incubated an additional 20 min at 30 1C under gentle shaking
(200 RPM) in 2 mL KHBþ radiolabelled [3H]-2-Deoxyglucose (2-DG)
(1.5 μCi/mL) with either 0, or for contralateral muscles, 2 mU/mL insulin
(Sigma). Muscles were quickly removed, rinsed in sterile saline, and
washed 3 5 min (100 RPM) in ice-cold KHB to clear extracellular
space of 2-DG [33]. Muscles were then rinsed again in sterile saline,
blotted with ﬁlter paper, weighed, and homogenized in 1 M KOH at
70 1C with periodic agitation for 15 min. Homogenates were centrifuged
10,000g at 4 1C for 5 min to clear insoluble components, and super-
natants were pipetted into vials with 10 mL scintillation cocktail and
[3H]-2-DG disintegrations per minute (dpm) for each vial were
determined using a scintillation counter.
2.12. Glucose oxidation
All experiments were performed on mKO and control mice, and 24-h
fasted control mice, between ZT8 and ZT12, again to coincide with the
hours near awakening and the normal physiological peak of glucose
tolerance and insulin sensitivity [14]. The method to measure glucose
oxidation was similar to that previously described [34] with some
modiﬁcations. Mice were sacriﬁced by cervical dislocation, and
diaphragm muscles were rapidly and carefully removed, blotted, cut
in half, weighed, and pre-incubated for 30 min at 37 1C under gentle
shaking (200 RPM) in 0.5 mL of a daily prepared, pre-gassed (1 h, 95%
O2þ5% CO2) modiﬁed Krebs–Henseleit buffer (KHB): 118 mM NaCl,
4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 15 mM
CO2
gassed NaHCO3, 1% fatty acid free BSA, 5 mM glucose, and31www.molecularmetabolism.comccess under CC BY-NC-SA license.
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Figure 1: Characterization of skeletal muscle-specific Bmal1 knockout mice. (A) Survival curve of muscle-specific Bmal1 knockout mice (mKO) and control littermates (Ctrl) (n¼12/group).
(B) Body weight of control and mKO mice (mean7SEM; n¼7–10/group/age; **po0.01, 2-way ANOVA with the Bonferroni correction). (C) Weight of fast tibialis anterior (TA) and slow soleus
(SOL) skeletal muscles from 5-month old mKO and control littermates (mean7SEM; n¼36/group; ***po0.001, Student’s t-test). (D) Epididymal fat pad weight from 5-month old mKO and
control littermates (mean7SEM; n¼4/group). (E) Fiber type profile of slow soleus (SOL) and fast extensor digitorum longus (EDL) in transverse sections stained with anti-myosin antibodies
specific for type-1/slow (blue), type-2A (green) and type 2B (red) myosin heavy chains. Type 2X fibers are unstained and appear black. Scale bar is 200 mm. (F) Quantitation of the relative
proportion of the different fiber types in SOL and EDL (mean7SEM, n¼8 muscles per group with >90% of fibers measured; see methods; *po0.05, Student’s t-test). (G) Hematoxylin and
eosin staining of transverse cryosections of SOL muscles from 26-month old mKO and control littermate. Scale bar is 50 mm. (H) In vivo muscle force measurements performed on gastrocnemius
muscles from 5-month old mKO and control littermates. Force normalized to muscle weight (mean7SEM, n¼8–10 muscles per group; **po0.01, ***po0.001, 2-way ANOVA with
Bonferroni correction). (I) Body weight of 7-month old inducible muscle-specific Bmal1 knockout mice (imKO, n¼7) and control littermates (Ctrl, n¼5) measured 5 months after tamoxifen
injections (mean7SEM). (J) Weight of TA and SOL skeletal muscles from 7-month old imKO and control littermates measured 5 months after tamoxifen injections (mean7SEM; n¼10–14/
group). (K) In vivo muscle force measurements performed on gastrocnemius muscles from 7-month old imKO and control littermates 5 months after tamoxifen injection. Force normalized to muscle
weight (mean7SEM, n¼8–10 muscles per group).
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10 mM HEPES. Thereafter, muscles were incubated an additional
90 min at 37 1C under gentle shaking (200 RPM) in 0.5 mL KHBþ ra-
diolabelled [1-14C]-glucose (0.5 μCi/mL). Reactions were terminated by
addition of 100 μL 1 M perchloric acid, and the CO2 produced during the
incubation was trapped in 100 μL NaOH that had been added to a small
tube inside the reaction vial. Glucose oxidation rates were determined by
measuring incorporation into 14CO2 by liquid scintillation counting.
2.13. PDHa activity
The activity of PDH in the active form (PDHa) was determined as
previously described [35–37] after homogenization of 10–15 mg
gastrocnemius muscle on ice, for 50 s using a glass homogenizer
(Kontes, Vineland, NJ, USA) and quick-frozen in liquid nitrogen.
2.14. SDS-PAGE and western blotting
Muscle lysates were prepared as previously reported [38], protein
concentration determined using the bicinchoninic acid assay (Pierce,
Rockford, IL, USA) and SDS-PAGE performed using 10% hand-cast gels.
Western blotting analysis was performed using speciﬁc antibodies to
BMAL1 (kind gift from Dr. Charles Weitz), AKT1, AKT2 and HK2 (cell
signaling), β Tubulin and Actin (Santa Cruz), phospho-AKT Ser473 and
phospho-AKT Thr308 (Millipore), GLUT4 (Thermo Scientiﬁc), TBC1D1
(kind gift from Prof. Dr. Hadi Al-Hasani), PDH-E1α, phospho-PDH-E1α
Ser300, and PDK4 (kind gifts from Prof. Grahame Hardie) and PDP1 (kind
gift from Dr. Brian Robinson). The bands were visualized and quantiﬁed
(Carestream Health, Rochester, NY, USA), then normalized by an internal
standard [38].
2.15. Statistical analysis
All data are expressed as means7SEM unless otherwise stated.
Statistical analysis was performed using unpaired Student's t-test or 2-
way analysis of variant (ANOVA). When ANOVA revealed signiﬁcant
differences, further analysis was performed using Bonferroni's multiple
comparison test. Differences between groups were considered statis-
tically signiﬁcant for po0.05.3. RESULTS
3.1. Muscle-speciﬁc Bmal1 knockout mice
To determine the role of the muscle clock, we produced two mouse
lines with skeletal muscle-speciﬁc knockout of Bmal1 (Arntl), an
essential component of the core clock. The ﬁrst line was a traditional
tissue-speciﬁc knockout, for which we bred mice with a ﬂoxed Bmal1
allele (Bmal1ﬂ/ﬂ) [18] with mice carrying a Cre recombinase transgene
under control of the Mlc1f promoter (Mlc1f–Cre), which is speciﬁcally
active in skeletal muscle [19] (Figure S1A). The resulting muscle-
speciﬁc knockout (hereafter referred to as mKO) mice showed a
disrupted Bmal1 gene in skeletal muscles but not in heart and liver
(Figure S1B) and markedly decreased levels of BMAL1 protein in skeletal
muscle (Figure S1C). Bmal1 transcripts were reduced across the
circadian cycle in both fast muscles (tibialis anterior, TA) and slow
muscles (soleus, SOL) compared to control littermates (Bmal1ﬂ/ﬂ;
Cre / ), whereas Bmal1 levels and rhythmic expression were
unchanged in cardiac muscle (Figure S1D). We also generated an
inducible muscle-speciﬁc Bmal1 knockout line (hereafter referred to as
imKO) by crossing ﬂoxed Bmal1 mice with HSA-Cre-ER mice, in which
the human skeletal actin promoter controls a chimeric Cre recombinase
fused with a mutated estrogen receptor that can be activated by
tamoxifen [20] (Figure S1E). Two-month-old imKO mice and their controlMOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The Authors. Published by Elsevier GmbH. Open alittermates were treated with tamoxifen daily for 5 days and examined at
1 or 5 months after tamoxifen treatment. Cre-mediated recombination of
the Bmal1 gene was seen in skeletal muscles but not in the heart
(Figure S1F). Bmal1 transcripts were reduced across the circadian
cycle in skeletal muscles from imKO mice after tamoxifen treatment
(Figure S1G), and BMAL1 protein levels were likewise markedly reduced
(Figure S1H).
The phenotype of mKO mice was strikingly different from that of whole
body Bmal1 knockout mice. Mice with whole body Bmal1 knockout were
reported to stop growing around 16 weeks of age, display progressive
arthropathy, sarcopenia and loss of fat tissue, and die between 26 and
52 weeks of age [39,40]. In contrast, mKO mice had a normal life span
(Figure 1A) and growth curve (Figure 1B), with body weight being
slightly increased compared to controls at advanced age. The weight of
both fast and slow hindlimb muscles was signiﬁcantly increased
compared to controls (Figure 1C). In contrast, no signiﬁcant difference
was seen in the weight of epididymal fat pads (Figure 1D). The ﬁber type
proﬁle of mKO mice was similar to controls, with the slow soleus
predominantly composed of type 1 and 2A ﬁbers, with few type 2X
ﬁbers, and the fast extensor digitorum longus (EDL) predominantly
composed of type 2B and 2X ﬁbers, with few type 2A ﬁbers (Figure 1E).
However, quantitative analysis revealed a slight decrease in type 1 and a
corresponding increase in type 2A ﬁbers in soleus, and a very slight
decrease in the relative proportion of type 2X ﬁbers in EDL (Figure 1F).
Muscle histology was apparently normal in mKO muscles even at
advanced age, with no sign of ﬁber degeneration or regeneration or
ﬁbrosis (Figure 1G). Muscle force, as determined in vivo, showed a
signiﬁcant decrease when normalized for muscle mass (Figure 1H).
A similar decrease in muscle force was previously reported for whole
body Bmal1 knockout mice, which also show a disruption of sarcomere
architecture, with loss of the regular disposition of thick and thin
ﬁlaments [41]. However, electron microscopy revealed no signiﬁcant
change in muscle ultrastructure of mKO muscles: in particular,
sarcomeres showed regular banding pattern and the hexagonal
disposition of thick and thin ﬁlaments in cross-section was normal
(Figure S2).
The phenotype of imKO mice was similar to that of controls when
examined at 1 or 5 months after tamoxifen treatment both with respect
to body weight (Figure 1I) and muscle weight (Figure 1J). Muscle
histology and ﬁber type proﬁle were normal (not shown) and force
production was not signiﬁcantly different when compared to controls
(Figure 1K). In contrast with global Bmal1 knockout, which results in
loss of circadian rhythm of locomotor activity and reduced total activity
levels [42], the circadian rhythm of locomotor activity was normal in
muscle-speciﬁc Bmal1 knockout and imKO mice, but surprisingly
activity levels were increased during the dark phase in mKO mice
(Figure S3).
3.2. Clock gene expression and circadian transcriptome changes in
mKO muscles
Bmal1-dependent genes, including Rev-erbα, Rev-erbβ, Dbp, Tef, Hlf,
and Cry2, showed markedly reduced oscillation in TA muscles from
mKO mice according to microarray analysis (Figure 2A) and qPCR of
selected genes (Figure S4). Similar changes were detected in SOL
muscles (Figure S5). Per1 expression was also reduced, but Per2 levels
were only slightly affected. In contrast, Clock, Npas2 and E4bp4 (Nﬁl3)
were all upregulated in mKO muscles. The Bmal1 paralog, Bmal2
(Arntl2/Mop9), which is downregulated in the liver of Bmal1 null mice
[42] and can functionally replace Bmal1 [43], was found to be expressed
at low levels without daily ﬂuctuations in mouse skeletal muscle, and33www.molecularmetabolism.comccess under CC BY-NC-SA license.
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Original articlewas unchanged in mKO muscles (Figure S6). The various responses of
clock genes and clock-associated genes to Bmal1 inactivation were in
agreement with previous reports for global and tissue-speciﬁc Bmal1
knockouts [16]. For example, the fact that Per2 oscillation was only
mildly affected in mKO skeletal muscles likely reﬂects a role for
oscillating systemic signals in the regulation of this gene, as was
demonstrated in a liver-speciﬁc Bmal1 knockout [44,45].
Global gene expression was markedly altered in skeletal muscles from
mKO mice, with 931 genes in TA and 706 in SOL identiﬁed as
differentially regulated according to maSigPro analysis (Figure 2B). Out
of the 684 (Ctrl TA) and 1359 (Ctrl SOL) 24-h cycling genes identiﬁed by
the JTK_CYCLE algorithm [26], 487 genes in TA and 666 genes in SOL
lost their 24-h oscillation in the absence of Bmal1, showing that a
signiﬁcant proportion of cycling genes in mouse skeletal muscles is
controlled by the intrinsic muscle clock.
3.3. Impaired insulin-dependent glucose uptake in skeletal muscles
from mKO and imKO mice
Global changes in muscle gene expression were further examined by
Gene Set Enrichment Analysis (GSEA) [27] in order to identify
signiﬁcantly enriched signaling pathways altered by muscle-speciﬁc
Bmal1 knockout. The “KEGG insulin signaling pathway”, comprising 132
genes coding for various components of the insulin-dependent signaling
cascade, was among the top ranking gene sets altered in mKO muscles
(p¼0.024) in both TA (Figure S7A) and SOL muscles (Figure S7B).34 MOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The AuTranscriptome analysis indicated that the expression of a number of
genes coding for major components of the insulin signaling pathway,
including PI3K (p110), AKT1 and AKT2, were signiﬁcantly up- or down-
regulated in mKO muscles (Figure S8). Western blotting analyses
showed that AKT2, the critical isoform in insulin-dependent glucose
uptake, was also increased at the protein level in mKO muscles about
2-fold, whereas AKT1 was only slightly decreased (Figure S9).
To determine whether the gene expression changes shown by GSEA and
Western blotting analysis lead to functional alterations in muscle insulin
signaling, we measured rates of basal and insulin-stimulated glucose
transport with [3H]-2-Deoxyglucose (2-DG) in isolated SOL muscles from
mKO mice and their control littermates. Basal rates of 2-DG uptake were
not different between control and mKO muscles, and the rate increased
(þ72%) in control muscle as expected in response to insulin. However,
this increase was signiﬁcantly reduced in mKO muscles (only þ29%)
(Figure 3A). Reduced sensitivity to insulin was even more striking in the
inducible mKO model (imKO), in which no signiﬁcant effect of insulin
stimulation on glucose uptake was detected (Figure 3A). Next, we
examined whether reduced muscle insulin sensitivity had consequences
on global glucose homeostasis. Fasting blood glucose was unchanged in
mKO mice both at ZT0 and ZT12 (Figure 3B). Glucose tolerance and
insulin tolerance were likewise unchanged (Figure 3C and D), with
similar results obtained in imKO mice (Figure S10).
Muscle insulin resistance induced by high-fat-diet or obesity is
associated with dysregulation of the initial steps of insulin-signalingthors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-SA license.
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35MOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The Authors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-SA license.
mKO TA
Ctrl TA
0
1
2
0
1
2
3-phospho-
glycerate
dihydroxyacetone
phosphate
0
1
2
0
1
2
phosphoenol-
pyruvate pyruvate
0
1
2
0
6
12
18
glucose glucose-6-phosphate
0
5
10
15
0
1
2
3
fructose-6-
phosphate
fructose-1,6-
bisphosphate
*
S
ca
le
d 
in
te
ns
ity
S
ca
le
d 
in
te
ns
ity
ribitol
0.5
0.8
1.1
1.4
0.6
0.9
1.2
1.5
0.3
1.2
2.1
3.0
xylitol
galactitol
0.7
0.9
1.1
1.3
1.5
ribose
* *
* * * * ** * * *
0.3
1.0
1.7
2.4
fructose
* * *
0.6
0.8
1.0
1.2
1.4
xylulose
0   4    8  12  16  20 0   4    8  12  16  20 0   4    8  12  16  20   ZT (hr)
0   4    8  12  16  20 0   4    8  12  16  20 0   4    8  12  16  20   ZT (hr)0   4    8  12  16  20 
Figure 4: Altered sugar metabolites in skeletal muscles from Bmal1 mKO mice. (A) Diurnal variations of glycolytic metabolites in control (Ctrl) and mKO TA muscles (mean7SEM; n¼5/group/
timepoint; *po0.05, repeated measures ANOVA). (B) Diurnal changes of other sugar metabolites in Ctrl and mKO TA muscles (mean7SEM; n¼5/group/timepoint; *po0.05, repeated
measures ANOVA; see Table S1).
Original articlecascade leading to decreased AKT activation. We therefore examined
the effect of insulin on AKT phosphorylation in the same muscles used
for the glucose uptake assay. As shown in Figure 3E, a similar increase
in insulin-stimulated AKT phosphorylation at Ser473 and Thr308 was
detected in mKO and control muscles. Likewise, no signiﬁcant difference
in AKT phosphorylation was observed in muscles from mKO and control
mice examined throughout the day/night cycle (Figure 3F). Interestingly,
the diurnal cycle in phosphorylation state of AKT Ser473 in control
muscle, peaking in the middle of the active/feeding phase, was
unchanged in mKO muscle.
Next, we focused on the ﬁnal steps of the insulin-signaling cascade
directly involved in glucose uptake. The expression of GLUT4, the
insulin-dependent glucose transporter, showed only modest, but
signiﬁcantly decreased expression at the transcript level (group effect
po0.05, 2-way ANOVA; Figure S8). This change was even more
evident at the protein level, with signiﬁcant reductions particularly at
ZT0, ZT12 and ZT16 (Figure 3G and H). Robust reductions in both
transcript and protein levels were similarly observed for hexokinase 2
(HK2) (Figures S8 and 3I, J). AKT is known to control skeletal muscle
glucose transport by phosphorylating the Rab-GTPase-activating pro-
teins TBC1D4 (AS160) and TBC1D1, thus promoting the translocation of
GLUT4 to the plasma membrane [46–48]. As shown in Figure 3K and L,36 MOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The AuTbc1d4 transcript levels were essentially unchanged in mKO muscles,
whereas Tbc1d1 transcripts were markedly downregulated. Based on
the JTK_CYCLE algorithm, and in agreement with circadian gene
expression proﬁles obtained from high-resolution DNA microarray
experiments (http://bioinf.itmat.upenn.edu/circa/mouse), Tbc1d1 tran-
scripts display a circadian rhythm in skeletal muscles with a peak during
the active phase, and their oscillation is blunted in both slow and fast
mKO muscles (Figure 3L). TBC1D1 protein levels were also markedly
reduced across the day/night cycle in mKO muscles (Figure 3M and N).
Tbc1d1 was previously identiﬁed as a circadian gene also in bone and
atrial myocardium [49] and a comparative computational screen for
conserved putative CLOCK:BMAL1-binding elements in the mouse and
human genomes identiﬁed a potential cis-regulatory CLOCK:BMAL1
binding site within Tbc1d1 [50]. We observed that this 18 bp sequence
is located in a non-coding region that is highly conserved among
different mammalian species (Figure S11). Although a non-canonical
E-Box, the core binding motif CACGGG was shown to efﬁciently bind the
CLOCK:BMAL1 heterodimer in a screen for circadian transcription factor
DNA binding activity [51]. Interestingly, Tbc1d1 knockout mice showed
decreased insulin-dependent glucose uptake in isolated skeletal mus-
cles, and GLUT4 protein abundance was similarly reduced by approxi-
mately 50% [52].thors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-SA license.
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To gain further insight into the effect of muscle-speciﬁc Bmal1 KO on
glucose metabolism, we examined the circadian metabolome of control
and mKO muscles. Diurnal steady state levels of glycolytic intermediates
were similar in mKO and control muscles, with a tendency for the initial
metabolites of the glycolytic pathway, such as glucose-6-phosphate and
fructose-6-phosphate, to show distinct diurnal ﬂuctuations, with peak
levels during the active/feeding phase and reduced levels during the
rest/fasting phase (Figure 4A). In contrast, mKO muscles showed
signiﬁcantly increased levels of a wide range of metabolites from
pathways linked to glycolysis, including the pentose phosphate pathway
(xylulose-5P, ribose, ribulose), the polyol pathway (sorbitol, galactitol,
fructose) and the glucuronic acid pathway (xylitol, xylulose) (Figure 4B
and Table S1). Interestingly, many of these sugar metabolites increased
especially or exclusively during the active/feeding phase, i.e. the time
when glycolytic intermediates were increased in both Ctrl and mKO
muscles. To test whether muscle glucose oxidation was impaired in
mKO muscles, we measured in vitro [1-14C]-glucose oxidation rates in
control and mKO muscles around ZT12, at the start of the active/feeding
phase. Glucose oxidation rate was signiﬁcantly decreased by 37%MOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The Authors. Published by Elsevier GmbH. Open ain muscles from mKO mice compared to control, similar to the 51%
reduction observed in control muscles after a 24-h fast (Figure 5A).
A crucial step in glucose oxidation is the irreversible oxidative
decarboxylation of pyruvate to acetyl-CoA catalyzed by the pyruvate
dehydrogenase (PDH) complex, a multisubunit mitochondrial complex.
The PDH-E1α subunit catalyzes the rate-limiting step in the overall
reaction, with the rate of conversion determined by the amount of PDH-
E1α in the dephosphorylated active state (PDHa). We examined PDHa
activity in muscles from control and mKO mice over 24 h and found that
in control muscles, PDHa activity oscillated with a peak at ZT8-ZT12
(Figure 5B), immediately before and during the transition from the rest/
fasting phase to the active/feeding phase. Similar diurnal ﬂuctuations in
PDHa activity were also reported in cardiac muscle [53]. PDHa activity
was signiﬁcantly decreased in Bmal1 mKO skeletal muscles, and the
normal peak during the light/dark transition was completely abrogated
(Figure 5B). PDHa activity was similarly decreased in muscles from
inducible knockout (imKO) mice (Figure 5C).
Reduced PDHa activity suggests increased phosphorylation of the E1α
subunit of the PDH complex. Indeed, while protein levels of PDH-E1α
were unchanged in mKO muscles (Figure S12), Ser300 phosphorylation,37www.molecularmetabolism.comccess under CC BY-NC-SA license.
Original articlea site that increases in skeletal muscle after fasting [54], was
signiﬁcantly increased in mKO muscles (Figure 5D). Reversible phos-
phorylation of PDH-E1α is controlled by PDH kinases (PDK) and PDH
phosphatases (PDP). We therefore examined expression levels of Pdk4
and Pdp1, the genes coding for the major PDK and PDP isoforms
expressed in skeletal muscle. Pdk4 was previously identiﬁed as a
circadian gene in skeletal muscle [55] and in many other tissues [49].
As shown in Figure 5E, Pdk4 displayed normal peak expression during
the fasting phase in control muscles, but showed a marked shift in
expression phase in mKO muscles, persisting at high levels well into the
feeding phase. A similar shift in Pdk4 expression was previously
observed in muscles from a global Clock mutant [55]. Consistent
results were seen in imKO mice examined 5 months after tamoxifen
treatment (Figure S13), again with Pdk4 transcripts increased in imKO
muscles at ZT12 compared to control littermates. PDK4 protein levels
closely followed transcript levels, and were signiﬁcantly increased in
mKO muscles immediately before and during the active/feeding phase
(Figure 5F). On the other hand, using JTK_CYCLE we identiﬁed Pdp1 as
a 24-h cycling gene in both TA and SOL muscles, with a peak between
ZT8 and ZT12, i.e. in the hours preceding the active/feeding phase.
Pdp1 was also previously reported to be a circadian gene in the brain
(listed as Ppm2c) [49]. As shown in Figure 5G, Pdp1 was markedly
downregulated, and its oscillation completely abolished in muscles
lacking Bmal1. Similar results were seen in muscles from the inducible
knockout (imKO), with Pdp1 transcripts clearly reduced at all timepoints
5 months after tamoxifen (Figure S13). PDP1 protein levels were
similarly reduced across the day/night cycle in mKO muscles (Figure 5H
and I). Potential CLOCK:BMAL1-dependent E-boxes have not been
described for either Pdk4 or Pdp1. However, Pdp1 (listed as Gene ID
381511) was previously identiﬁed among the top 100 genes with
conserved putative D-box cis-regulatory elements [50]. The D-box
transcriptional activators Dbp, Hlf and Tef are all direct targets of
Bmal1, as is the D-Box transcriptional repressor E4bp4 (Nﬁl3) [8]. We
found that this D-box sequence, located within the second intron of
Pdp1, shows a high degree of conservation among many mammalian
species in addition to human and mouse (Figure S14), suggesting Pdp1
may be an indirect Bmal1 target.4. DISCUSSION
Skeletal muscle is a major site of insulin-stimulated glucose disposal
[56] and muscle insulin resistance has been considered to be one of the
earliest factors in the pathogenesis of the metabolic syndrome [57]. The
dissection of the mechanisms controlling muscle insulin sensitivity may
therefore have important implications for understanding the causes of
metabolic diseases. Circadian rhythms control body metabolism and
their disruption is known to increase the risk for metabolic syndrome;
however the relative roles of central and peripheral clocks remain to be
established. Changes in skeletal muscle structure and function were
described in a global Bmal1 knockout model [41]; however it is unclear
whether these are direct consequences of muscle Bmal1 deﬁciency or
secondary effects due to the disruption of the circadian pacemaker or
other peripheral clocks. Global Bmal1 knockout causes not only loss of
circadian rhythm of locomotor activity but also reduced total activity
levels [42] and rescue experiments in which BMAL1 was constitutively
expressed in skeletal muscle of Bmal1 null mice showed that muscle-
speciﬁc rescue restored activity levels, though not circadian rhythmicity
of activity [58]. This result was interpreted as indicating that BMAL1
function in muscle is important for activity. However, interpretation of38 MOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The Authis experiment is complicated by the fact that the Bmal1 transgene
used for the rescue was controlled by an α-actin promoter expressed at
constitutively high levels in skeletal muscle, without any circadian
oscillation.
We show here that muscle-speciﬁc Bmal1 inactivation does not cause
the dramatic changes seen in whole body Bmal1 knockout, such as
progressive sarcopenia and premature aging. The phenotype of both
knockout models examined here was essentially normal, except for a
slight change in ﬁber type composition and decrease in muscle force in
the mKO but not in the imKO line. Locomotor activity showed a normal
circadian rhythm in both lines; however the total activity levels during
the dark phase were signiﬁcantly increased compared to control in the
mKO but not in imKO line. The cause of these differences remains to be
established and probably reﬂects changes taking place during develop-
ment in the mKO model. Importantly, in spite of these differences, the
effect on glucose metabolism was essentially similar in the two muscle-
speciﬁc Bmal1 knockout lines.
The main result of this study is the ﬁnding that disruption of the intrinsic
muscle clock causes muscle insulin resistance and altered muscle
glucose metabolism. Insulin-dependent glucose uptake in isolated
muscles was reduced by muscle-speciﬁc inactivation of Bmal1, induced
either at early developmental stages (mKO) or in the adult (imKO). In
contrast, no signiﬁcant change in global glucose tolerance was observed
in the absence of muscle Bmal1. Muscle insulin resistance without
changes in global glucose tolerance was previously described in mice
with muscle-speciﬁc knockout of the insulin receptor [30]. It is likely that
other insulin-sensitive tissues, such as adipose tissue, compensate for
reduced muscle insulin sensitivity at the whole body level [59].
What is the cause of the altered response to insulin in muscles from
Bmal1 mKO mice? The canonical insulin signaling pathway is apparently
not responsible for this change, since AKT phosphorylation, which is
reduced in obesity and diabetes [60], was unchanged, and was similarly
increased by insulin in muscles from control and Bmal1 mKO mice
(Figure 3E). Other experimental conditions, such as lipid infusion [61–
63], and skeletal muscle-speciﬁc genetic models, such as overexpres-
sion of PPARα [64] or inactivation of carnitine acetyltransferase [65],
were also shown to cause muscle insulin resistance without affecting
AKT phosphorylation. On the other hand, our results suggest that two
major changes in muscle-speciﬁc Bmal1 knockout muscles may be
linked to muscle insulin resistance and altered glucose metabolism:
(1) reduced GLUT4 protein levels, with reduced expression and altered
circadian oscillation of TBC1D1; (2) reduced PDH activity due to altered
expression of Pdp1 and Pdk4, two circadian genes coding for the crucial
PDH regulators (Figure 6).
In Bmal1 mKO muscles, GLUT4 protein levels were signiﬁcantly reduced
by 45% across the diurnal cycle compared to control levels (Figure 3G
and H). This change is likely relevant, because skeletal muscle-speciﬁc
GLUT4þ / mice, which have a 40–50% reduction in GLUT4 protein in
skeletal muscles, also show a partial reduction in insulin-stimulated
glucose uptake in skeletal muscles [66]. GLUT4 trafﬁc to the plasma
membrane is controlled by two Rab-GTPase-activating proteins: TBC1D1
and its paralog TBC1D4 (AS160) [67]. While Tbc1d4 expression was
essentially unaffected by Bmal1 knockout, Tbc1d1 was strongly down-
regulated in mKO skeletal muscle (Figure 3G and H) resulting in reduced
circadian TBC1D1 protein levels (Figure 3M). Interestingly, Tbc1d1
knockout mice were recently reported to show a 50% reduction in
GLUT4 levels and impaired insulin-stimulated glucose uptake in skeletal
muscle [52]. A similar effect was previously described in a recombinant
mouse strain carrying a mutation of Tbc1d1 [48,68]. Our results
therefore suggest that the loss of Bmal1 in skeletal muscle leads tothors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-SA license.
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Figure 6: Glucose metabolism in skeletal muscles of Bmal1 mKO mice. In control mice
glucose uptake is normally enhanced by insulin at the transition from the rest/fasting to the
active/feeding phase, and PDH activity is increased by upregulation of PDP1 and downregulation
of PDK4. In Bmal1 mKO mice, insulin-dependent glucose uptake is impaired due to decreased
GLUT4 and TBC1D1 protein levels. As a result of reduced HK2 and PDHa activity, glucose
metabolism is channeled to alternative pathways, including the polyol, pentose phosphate and
glucuronic acid pathways.reduced Tbc1d1 oscillation and expression levels, which in turn leads to
reduced GLUT4 levels and insulin-stimulated glucose uptake, as
previously suggested for the Tbc1d1 knockout model [52]. Interestingly,
in both Tbc1d1 null mice and mKO mice GLUT4 protein was markedly
reduced, whereas Glut4 mRNA levels were barely affected. In the case
of Tbc1d1 null mice, it was suggested that GLUT4 protein changes are
not due to an alteration of transcriptional regulation of the gene, but
reﬂect a post-translational event possibly controlled by TBC1D1 [52].
One possibility is that TBC1D1 affects GLUT4 protein stability, but this
remains to be established.
Glucose oxidation in Bmal1 mKO muscles is impaired by reduced PDH
activity due to altered expression of two circadian genes, Pdp1 and
Pdk4. During the rest/fasting phase, reduced insulin and contractile
activity levels decrease glucose uptake and glycolytic ﬂux in muscle
cells, while promoting fatty acid β-oxidation, further inhibiting glucose
oxidation by PDK4 activation and PDH inhibition [69]. During the active/
feeding phase, skeletal muscle glucose uptake and oxidation are both
stimulated by a rise in blood glucose and insulin secretion, in
conjunction with increased locomotor activity. At this stage, PDP1,
which is stimulated by contractile activity-dependent increase in
intracellular Ca2þ , dephosphorylates PDH-E1α, thus activating the
PDH complex. Our results suggest that circadian PDH activity is driven
by the intrinsic muscle clock, with PDHa normally activated in
anticipation of the active/feeding phase by increased expression of
Pdp1. In the absence of Bmal1, Pdp1 oscillation and expression is
severely impaired, while Pdk4 levels and PDH phosphorylation remain
high also during the active/feeding phase. PDH thus remains partially
“locked” in a fasting state during the light/dark transition when it is
normally activated. We suggest that as a result of the PDH block,
glycolysis is partially uncoupled from glucose oxidation in Bmal1 KO
muscles, and glycolytic ﬂux in the context of PDH inhibition leads to the
diversion of glycolytic intermediates to alternative metabolic fates,
including the pentose phosphate and glucuronic acid pathways, with
the shunting of glucose to the polyol pathway being favored by the
concomitant decrease in HK2 levels (Figure 6).
In conclusion, we report here that a major physiological role of the
muscle clock is to prepare muscle cells for the transition from the rest/
fasting phase to the active/feeding phase, in anticipation of periodic
ﬂuctuations in fuel supply and demand. Reduced PDH activity and the
concomitant block in insulin-stimulated glucose uptake are expected to
impair the switch from lipid to glucose metabolism at the light/darkMOLECULAR METABOLISM 3 (2014) 29–41 & 2013 The Authors. Published by Elsevier GmbH. Open atransition. Skeletal muscles with functional clocks are thus primed to
choose “the right fuel at the right time“ [70], whereas muscle-speciﬁc
Bmal1 inactivation and the consequent disruption of the muscle clock
would cause a state of reduced metabolic ﬂexibility [71], characterized
by muscle insulin resistance and altered glucose metabolism.ACKNOWLEDGMENTS
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